From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure

Imatinib is a targeted cancer therapy that has significantly improved the care of patients with chronic myeloid leukemia (CML) and gastrointestinal stromal tumor (GIST). However, it has been shown that the recommended dosages of imatinib are associated with trough plasma concentration (Cmin) lower t...

Descripción completa

Detalles Bibliográficos
Autores principales: Goutelle, Sylvain, Guidi, Monia, Gotta, Verena, Csajka, Chantal, Buclin, Thierry, Widmer, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142039/
https://www.ncbi.nlm.nih.gov/pubmed/37111566
http://dx.doi.org/10.3390/pharmaceutics15041081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142039/
https://www.ncbi.nlm.nih.gov/pubmed/37111566
http://dx.doi.org/10.3390/pharmaceutics15041081

Ejemplares similares